Literature DB >> 9047234

cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro.

R R Nepomuceno1, A H Henschen-Edman, W H Burgess, A J Tenner.   

Abstract

The complement protein C1q, mannose-binding lectin (MBL), and pulmonary surfactant protein A (SPA) are structurally similar molecules that enhance phagocytic function in vitro. Monoclonal antibodies R3 and R139, which inhibit the enhancement triggered by these three ligands, were used to purify a 126,000 M(r) cell surface protein designated C1qR(P). Amino acid sequence was obtained and the corresponding cDNA was cloned. C1qR(P) is a novel type I membrane protein with the following putative structural elements: a C-type carbohydrate recognition domain, five EGF-like domains, a transmembrane domain, and a short cytoplasmic tail. All peptides identified by amino acid sequencing are encoded by the cDNA. Additionally, an anti-peptide antiserum was generated, which is reactive with C1qR(P). The data indicate that the cloned cDNA encodes the receptor that plays a role in C1q/MBL/SPA-mediated removal or destruction of pathogens and immune complexes by phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9047234     DOI: 10.1016/s1074-7613(00)80419-7

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  52 in total

Review 1.  C1q receptors.

Authors:  P Eggleton; A J Tenner; K B Reid
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

2.  CD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow niche.

Authors:  Stéphane Chevrier; Céline Genton; Axel Kallies; Alexander Karnowski; Luc A Otten; Bernard Malissen; Marie Malissen; Marina Botto; Lynn M Corcoran; Stephen L Nutt; Hans Acha-Orbea
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-19       Impact factor: 11.205

3.  Modulated interaction of the ERM protein, moesin, with CD93.

Authors:  Mingyu Zhang; Suzanne S Bohlson; Marisela Dy; Andrea J Tenner
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

4.  Detection and characterization of soluble CD93 released during inflammation.

Authors:  Mallary C Greenlee; Sarah A Sullivan; Suzanne Slater Bohlson
Journal:  Inflamm Res       Date:  2009-07-15       Impact factor: 4.575

5.  Regulation of protein phosphorylation and pathogen phagocytosis by surfactant protein A.

Authors:  T L Schagat; M J Tino; J R Wright
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

6.  Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding proteindependent cell-mediated cytotoxicity.

Authors:  Y Ma; K Uemura; S Oka; Y Kozutsumi; N Kawasaki; T Kawasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

7.  Relative roles of complement factor 3 and mannose-binding lectin in host defense against infection.

Authors:  Kazue Takahashi; Lei Shi; Lakshmi D Gowda; R Alan B Ezekowitz
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

8.  CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia.

Authors:  Masayuki Iwasaki; Michaela Liedtke; Andrew J Gentles; Michael L Cleary
Journal:  Cell Stem Cell       Date:  2015-09-18       Impact factor: 24.633

9.  Murine low-density lipoprotein receptor-related protein 1 (LRP) is required for phagocytosis of targets bearing LRP ligands but is not required for C1q-triggered enhancement of phagocytosis.

Authors:  Anna P Lillis; Mallary C Greenlee; Irina Mikhailenko; Salvatore V Pizzo; Andrea J Tenner; Dudley K Strickland; Suzanne S Bohlson
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes.

Authors:  Peter Garred; Morten A Nielsen; Jørgen A L Kurtzhals; Rajneesh Malhotra; Hans O Madsen; Bamenla Q Goka; Bartholomew D Akanmori; Robert B Sim; Lars Hviid
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.